Mean age (yr) |
65 (range, 31–93) |
66 (range, 23–96) |
65 (range, 23–96) |
Male sex (%) |
62 (124/199) |
56 (168/301) |
58 (292/500) |
Median NIHSS score |
18 (IQR, 14–22) |
17 (IQR, 15–21) |
18 (IQR, 14–22) |
Median ASPECTS |
9 (IQR, 8–10) |
9 (IQR, 7–10) |
9 (IQR, 8–10) |
Diabetes mellitus (%) |
11 (21/199) |
16 (47/301) |
14 (68/500) |
Atrial fibrillation (%) |
27 (54/199) |
27 (81/301) |
27 (135/500) |
Previous stroke (%) |
10 (20/199) |
11 (34/301) |
11 (54/500) |
IAT (%) |
39 (78/199) |
51 (155/301) |
47 (233/500) |
Median thrombus length (mm) (n = 186) |
15.6 (IQR, 10.3–22.2) (range, 4.8–39.5) |
|
|
Median thrombus volume (mm3) (n = 186) |
70.1 (IQR, 49.3–113.3) (range, 6.1–456.7) |
|
|
Median distance to thrombus (mm) |
6.4 (IQR, 0.0–13.5) (range, 0.0–38.2) |
|
|
T-occlusion (%) |
23 (46/199) |
29 (88/301) |
27 (134/500) |
Median density thrombus NCCT (HU) |
49.0 (IQR, 44.5–55.4) (range, 33.1–67.8) |
|
|
Median relative density thrombus NCCT (%) |
134.4 (IQR, 116.8–151.7) (range, 65.8–274.4) |
|
|
Median density thrombus CTA (HU) |
61.4 (IQR, 52.6–72.1) (range, 38.5–134.3) |
|
|
Median relative density thrombus CTA (%) |
29.8 (IQR, 21.4–40.8) (range, 12.2–94.7) |
|
|
Median thrombus attenuation increase (HU) |
11.4 (IQR, 0.1–22.5) (range, −9.9–80.0) |
|
|
Median thrombus void fraction (%) |
6.0 (IQR, 0.08–15.4) (range, −8.9–61.8) |
|
|